Pfizer has announced that its 2025 Annual Meeting of Shareholders will be held virtually on Thursday, April 24, 2025, at 9:00 a.m. EDT. The company has designed the virtual meeting to provide shareholders with the same rights and opportunities to participate as they would at an in-person meeting. Beginning today, shareholders can register for the virtual meeting and access additional information at https://meetnow.global/PFE2025.
On the day of the meeting, shareholders can log in to the virtual meeting platform at 8:45 a.m. EDT using their control number, which can be found on their proxy card, voting instruction form, or notice. Only shareholders with a control number will be able to ask questions or vote during the live meeting. Beneficial owners who are required to obtain a legal proxy and pre-register may also vote or ask questions during the meeting.
Shareholders can submit questions in advance of the meeting by following the instructions provided on the “Rules of Conduct and Meeting Procedures” available on the virtual meeting platform. The deadline for submitting questions is 5:00 p.m. EDT on April 22.
The virtual meeting will be webcast and a replay will be available for up to one year at https://investors.pfizer.com/Investors/Events–Presentations.
Pfizer is a biopharmaceutical company that applies science and its global resources to bring therapies to people that extend and improve their lives. The company’s mission is to set the standard for quality, safety, and value in the discovery, development, and manufacture of healthcare products.
Note: The webcast of the meeting may include forward-looking statements that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.